Pretreatment smoking linked to poor prognosis in AI-treated patients

[News]

Among older aromatase inhibitor (AI)-treated patients with breast cancer, current smokers at treatment initiation have an increased risk of breast cancer events and distant metastases, say Swedish researchers.

More... (http://www.news-medical.net/news/20160623/Pretreatment-smoking-linked-to-poor-prognosis-in-AI-treated-patients.aspx)